IR Department
  • About Us
    • Overview
    • Our Team
    • Our ESG Position
    • Careers
  • Services
    • What We Do
    • Investor Relations
    • IPO Readiness
    • Media Relations
    • Issues and Crisis Communications
    • Digital Content & Social Media Activation
    • Marketing and Brand Campaigns
    • Video Production
    • ESG
    • ESG Competent Boards Masterclass
  • News & events
    • Blog
  • Contact
    • Contact Us
    • Email Alerts
IR Department Newsletter - September 2022
News & events >
  • Blog

Recent Posts

  • HealthInvest April 2025 recap: bringing life sciences to the forefront
  • Upcoming: HealthInvest April 2025
  • Equity Insights: December Issue
  • Navigating AGM Season: Insights from Jane Lowe
  • 3 ways new ESG management and auditing standards could affect all Australian listed companies

Archives

  • April 2025
  • March 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • May 2024
  • December 2023
  • October 2023
  • July 2023
  • March 2023
  • February 2023
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • March 2022
  • February 2022

Categories

  • AGMs
  • Crisis communications
  • Equity Insights
  • ESG
  • Investor relations
  • Newsletter March 2022
  • Newsletter Sept 2022
  • Uncategorized

IR Department client media highlights

Posted on August 31st, 2022 . Updated on August 31st, 2022 by Cherie Hartley

IR Department client media highlights:

 

Kazia Therapeutics

The Australian - Diversification is the key to drug development

Finance News Network - Stocks of the Hour

 

INOVIQ

Finance News Network - INOVIQ (ASX:IIQ) discusses US milestones

Proactive - INOVIQ expands US footprint with new sales team

 

Race Oncology

Stockhead - Dr Boreham's Crucible: Finish line in sight, Race prepare to hand over the baton

The Australian - Race Oncology breakthrough

 

Elixinol

Proactive - June quarter: biotech companies buck trend that says sector moves slowly

Business News Australia - Australia's top 20 cannabis companies

 

Servatus

BioSpectrum - Servatus strenghtens board with new appointment

Courier Mail - Sunshine Coast biomed company aiming to crack $38bn market

 

 

 

 

Posted in Newsletter Sept 2022

IR Department acknowledge the Traditional Owners of the land on which it operates and pays respect to Elders past, present and emerging.

Subscribe

Which of the following group do you best fit?

 
By subscribing you agree to with our Privacy Policy

Site Map Privacy Search
IR Department . All rights reserved. - Site by